prognostic stage iv breast cancer ajcc v8
Showing 51 - 55 of 55
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Withdrawn
- Anatomic Stage I Breast Cancer AJCC v8
- +23 more
- Lorcaserin
- +2 more
- (no location specified)
Jan 14, 2021
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8
Completed
- Anatomic Stage II Breast Cancer AJCC v8
- +20 more
- Mirvetuximab Soravtansine
-
Houston, TexasM D Anderson Cancer Center
Nov 18, 2020
Advanced Malignant Solid Tumor, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in
Completed
- Advanced Malignant Solid Neoplasm
- +24 more
- Oxidative Phosphorylation Inhibitor IACS-010759
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 23, 2020
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Negative, HER2/Neu Negative Trial in Portland (Durvalumab, Olaparib)
Completed
- Anatomic Stage IV Breast Cancer AJCC v8
- +5 more
- Durvalumab
- Olaparib
-
Portland, OregonOHSU Knight Cancer Institute
Nov 18, 2020
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, KIT Positive Trial in Houston (Imatinib Mesylate,
Completed
- Anatomic Stage IV Breast Cancer AJCC v8
- +6 more
- Imatinib Mesylate
- Letrozole
-
Houston, TexasM D Anderson Cancer Center
Jan 14, 2020